A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease. For patients with localized PDAC, surgery is the best option, but with a median survival of less than 2 years and a difficult and prolonged postoperative course for most, there is an urgent need to better identify patients...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Stratford, Jeran K., Bentrem, David J., Anderson, Judy M., Fan, Cheng, Volmar, Keith A., Marron, J. S., Routh, Elizabeth D., Caskey, Laura S., Samuel, Jonathan C., Der, Channing J., Thorne, Leigh B., Calvo, Benjamin F., Kim, Hong Jin, Talamonti, Mark S., Iacobuzio-Donahue, Christine A., Hollingsworth, Michael A., Perou, Charles M., Yeh, Jen Jen
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2010
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903589/
https://ncbi.nlm.nih.gov/pubmed/20644708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1000307
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы